ArticleClinical immunology (Orlando, Fla.)2020

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.

Dimitrios C Mastellos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.